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LETTER TO THE EDITOR
Cancer Registry data
Sir - It was encouraging to see such a worthwhile use of data
as that made by Dr Coleman and his colleagues in their
investigation of the relationship between leukaemia incidence
and electricity transmission equipment (Br. J. Cancer, 1989,
60, 793).
However, I must point out that their statement that 'it
was not possible to obtain direct measurements of field inten-
sity . . . since . . . it was a condition of access to the Thames
Cancer Registry data for the study that no contact would be
made with study subjects or their kin' (p. 794) is perhaps
misleading and indeed has been misconstrued by The Times
(29 November 1989).
If I may clarify the Registry's access conditions: contact
with patients or their relatives for interview is possible, pro-
vided that certain (albeit rather stringent) requirements are
met. The requirements include obtaining the approval of an
appropriate ethical committee and the permission of the
patient's treating consultants and general practitioners. I
must stress that restrictions to access are determined by the
ethical committees and the medical practitioners who have
responsibility for the care of each patient. The Thames
Cancer Registry is always at pains to make its data available
within this framework.
I would also point out that important interview studies
that use the Thames Cancer Registry data as a starting point
have been successfully undertaken (e.g. the widely publicised
study of oral contraceptive use and breast cancer risk in
young women in the Lancet, May 1989).
We welcome similar uses of our data.
Yours etc.,
H. Thornton-Jones
Registry Director,
The Thames Cancer Registry,
Clifton Avenue, Belmont,
Sutton, Surrey SM2 5PY, UK.
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